.Amgen has shared (PDF) the first phase 3 data on its $400 million dermatitis medicine, linking the ...
.Biogen and also UCB's gamble on advancing right into phase 3 astride a failed research hopes to hav...
.Italian biotech Aptadir Therapies has released with the promise that its pipe of preclinical RNA pr...
.Wave Lifestyle Sciences has actually satisfied its objective in a Duchenne muscular dystrophy (DMD)...
.After a handful of years in biotech, Mike Quigley, Ph.D., is actually returning to the pharma layer...
.Achilles Therapies has actually wrecked its method. The British biotech is quiting working on its c...
.Aligos Rehabs is trumpeting a midstage win in metabolic-dysfunction associated steatohepatitis (MAS...
.Basilea Pharmaceutica's work building brand new antifungals has gotten a considerable boost from th...
.Possessing presently scooped up the U.S. rights to Capricor Therapies' late-stage Duchenne muscular...
.After pushing back the selection date for Applied Rehabs' metabolic problem medication govorestat, ...